NCT00235079View on ClinicalTrials.gov

Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.

PHASE4CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

PericarditisRecurrence

Interventions

DRUG

Colchicine

Colchicine 0.5mg BID (\>70Kg) or 0.5 once daily for 6 months

DRUG

Placebo

Placebo comparator

Trial Locations (4)

10141

Cardiology Department. Maria Vittoria Hospital ASL3 Torino (Coordinating Center), Torino

Unknown

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

Ospedale Regionale, Bolzano

Ospedale di Rivoli, Rivoli

All Listed Sponsors

lead

Azienda Sanitaria Locale 3, Torino

OTHER

NCT00235079 - Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment. | Biotech Hunter | Biotech Hunter